Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Acute Myeloid Leukemia With Philadelphia Chromosome and Complex Karyotype: A Diagnostic Dilemma.

Cureus·2026
Same author

Augmented Reality in Temporomandibular Joint Arthrocentesis - An Evaluative Clinical Study.

Annals of maxillofacial surgery·2025
Same author

Epigenetic Control of Redox Pathways in Cancer Progression.

Antioxidants & redox signaling·2025
Same author

Low-Level Laser Therapy with Pharmacotherapy in the Management of Myofascial Pain Dysfunction Syndrome with or without Other Temporomandibular Disorders.

Indian journal of dental research : official publication of Indian Society for Dental Research·2025
Same author

Alpha-cyperone mitigates renal ischemic injury via modulation of HDAC-2 expression in diabetes: Insights from molecular dynamics simulations and experimental evaluation.

European journal of pharmacology·2024
Same author

Comparative evaluation of two different dental age estimation methods using tooth pulp: A CBCT study.

The Medico-legal journal·2024

Related Experiment Video

Updated: May 22, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Association between altered thyroid state and insulin resistance.

Kunal B Kapadia1, Parloop A Bhatt, Jigna S Shah

  • 1Department of Clinical Pharmacy, Shri Sarvajanik Pharmacy College, Mehsana, India.

Journal of Pharmacology & Pharmacotherapeutics
|May 26, 2012
PubMed
Summary

Altered thyroid hormones, both hypo- and hyperthyroidism, are linked to insulin resistance (IR). This study found higher insulin levels and IR in both hypothyroid and hyperthyroid patients compared to euthyroid individuals.

Keywords:
Hypothyroidismhyperthyroidisminsulin resistance

More Related Videos

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Related Experiment Videos

Last Updated: May 22, 2026

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
09:48

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance

Published on: February 17, 2023

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
08:32

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain

Published on: January 4, 2018

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)
08:13

Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT)

Published on: January 7, 2018

Area of Science:

  • Endocrinology
  • Metabolic Disorders
  • Thyroid Research

Background:

  • Thyroid hormones play a crucial role in regulating metabolism.
  • Imbalances in thyroid function are associated with various metabolic disturbances.
  • Insulin resistance (IR) is a key factor in the development of type 2 diabetes and cardiovascular disease.

Purpose of the Study:

  • To investigate the association between altered thyroid hormone levels and insulin resistance.
  • To compare the degree of insulin resistance in hypothyroid and hyperthyroid patients versus euthyroid individuals.

Main Methods:

  • A cross-sectional study involving euthyroid (EU), hypothyroid (HO), and hyperthyroid (HR) patients.
  • Fasting blood samples were analyzed for thyroid stimulating hormone (TSH), glucose, insulin, and lipid profiles.
  • Insulin resistance was assessed using the Homeostatic Model Assessment (HOMA) index.

Main Results:

  • HOMA values and insulin levels were significantly higher in both HR and HO groups compared to the EU group (P < 0.05).
  • Patients with hypothyroidism (HO) showed significantly elevated cholesterol, triglycerides (TG), and low-density lipoprotein (LDL), with lower high-density lipoprotein (HDL) compared to EU and HR groups (P < 0.05).
  • HOMA and insulin levels positively correlated with TSH in HO patients and negatively correlated in HR patients.

Conclusions:

  • Both hypothyroidism and hyperthyroidism are associated with insulin resistance, mediated by mechanisms including altered insulin secretion and lipid profiles.
  • The degree of insulin resistance was comparable between hypothyroid and hyperthyroid patients.
  • Altered thyroid states can lead to insulin resistance, potentially contributing to glucose-related disorders like diabetes and dyslipidemia.